Jafar Ezzati Nazhad Dolatabadi | Nanotechnology | Best Researcher Award
Assoc. Prof. Dr. Jafar Ezzati Nazhad Dolatabadi, Tabriz University of Medical Sciences, Iran.
Dr. Jafar Ezzati Nazhad Dolatabadi is an Associate Professor at Tabriz University of Medical Sciences, specializing in pharmaceutical nanotechnology
. With a strong background in biochemistry and molecular research, he has contributed extensively to nanomedicine, drug delivery systems, and cancer therapy
. His research involves synthesizing and characterizing nanocarriers for drug delivery, cytotoxicity studies, and biophysical interactions. Dr. Dolatabadi has authored numerous publications in renowned journals
and presented at international conferences
. His ongoing research focuses on biosensors and molecular imprinting for medical and environmental applications.
Publication Profiles
Scopus
Education & Experience 

B.Sc. in Biology – Iran 
M.Sc. in Biochemistry – Razi University 
Ph.D. in Pharmaceutical Nanotechnology – Tabriz University of Medical Sciences 
Associate Professor at Tabriz University of Medical Sciences since 2014 
Published extensively in international journals 
Presented research at global conferences 
Summary Suitability
Dr. Jafar Ezzati Nazhad Dolatabadi, an Associate Professor at Tabriz University of Medical Sciences, has made exceptional contributions to the field of Pharmaceutical Nanotechnology. With a robust academic foundation and extensive experience in researching drug delivery systems, nanomedicine, and anticancer therapies, Dr. Dolatabadi’s work stands out for its profound impact on improving therapeutic strategies. His innovative research in designing and characterizing novel drug formulations, along with his emphasis on nanocarriers for enhanced drug delivery, has earned him recognition and accolades in the scientific community. His dedication to advancing the field of pharmaceutical sciences makes him a deserving candidate for the Best Researcher Award.
Professional Development 

Dr. Dolatabadi has significantly contributed to biomedical research with a focus on pharmaceutical nanotechnology
, drug delivery
, and cancer therapy
. He has worked on nanolipidic carriers, biomolecular interactions, and cytotoxicity studies to improve targeted drug formulations. His expertise extends to surface plasmon resonance, spectroscopy, and molecular imprinting for biosensing applications
. With over 20 research projects completed, his innovations aid in drug safety, targeted therapies, and environmental health monitoring
. His current research integrates nanotechnology with electrochemical biosensors, enhancing medical diagnostics and food safety testing
.
Research Focus
Awards & Honors 🏆🎖
International Research Awards in Pharmaceutical Nanotechnology 
Best Research Paper Awards in Nanomedicine & Biophysics 
Recognized at International Conferences for Biochemical Research 
Recipient of Prestigious Grants for Drug Delivery Innovations 
Academic Excellence Award for Contributions to Biomedical Science 
. His work involves developing nanolipidic carriers, dendrimers, and polymeric systems to improve drug bioavailability and targeting. He explores cytotoxicity and genotoxicity studies
. Additionally, he is working on biosensors for detecting contaminants in food and the environment
.
. 1 citation.
. 0 citations.
. 4 citations.
. He has published over 10 Scopus Q1 & Q2 papers, a Lancet Microbe article, and holds a UK design patent. 


and gene apoptosis studies enhances cancer treatment. As the Founder of Healthmeds Generics, he ensures affordable generic medicines for all. At Kairos Kinetic, he promotes science communication through Thursday webinars, earning the Science Popularisation Award 2024
enhance natural drug formulations. His innovative research is shaping the future of personalized medicine. 
Eco-friendly synthesis of ZnO nanoparticles fabricated using Fioria vitifolia L. and their biomedical potentials – Microbial Pathogenesis, 2025, 
Eco-friendly synthesis of betanin-conjugated zinc oxide nanoparticles: antimicrobial efficacy and apoptotic pathway activation in oral cancer cells – Molecular Biology Reports, 2024, Cited by: 2
Comment on, “Prospective analysis of STRATAFIX™ symmetric PDS plus suture for fascial closure in spinal surgery: a pilot study” – Neurosurgical Review, 2024,
Letter to editor: “Neuralink’s brain implant: a vision for enhanced human-machine integration” – Neurosurgical Review, 2024, 
Fioria vitifolia-mediated silver nanoparticles: Eco-friendly synthesis and biomedical potential – Journal of Water Process Engineering, 2024, Cited by: 4
Early detection and rapid diagnosis of circulating HPV-DNA detected using droplet digital PCR – Oral Oncology Reports, 2024,
Using proton therapy to treat head and neck cancer and oral squamous cell carcinoma – Oral Oncology Reports, 2024, 








Best Campus Leader Award: Monastic H.S.E.B, Janakpur.
Excellence in Physics Education Award: National School of Sciences, Kathmandu.
Outstanding Contribution to Physics Research: Amrit Science Campus, Kathmandu.
Distinguished Faculty Award: Trinity International College, Kathmandu.
. He has authored over 599 research articles, 12 patents, 23 books, and 44 book chapters 










Recognized among the Top 2% scientists globally based on career-long and single-year research impact
Multiple research awards for high-impact publications in leading journals














, where he studied equilibrium polymerization as a phase transition. His postdoctoral research at UCLA focused on Langmuir monolayers 
Research Focus

